Morgan Stanley’s Apellis Pharmaceuticals APLS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$169M Buy
9,752,201
+126,078
+1% +$2.18M 0.01% 960
2025
Q1
$211M Sell
9,626,123
-1,104
-0% -$24.1K 0.02% 815
2024
Q4
$307M Buy
9,627,227
+6,237,442
+184% +$199M 0.02% 648
2024
Q3
$97.8M Buy
3,389,785
+1,270,888
+60% +$36.7M 0.01% 1260
2024
Q2
$81.3M Buy
2,118,897
+481,279
+29% +$18.5M 0.01% 1326
2024
Q1
$96.3M Sell
1,637,618
-4,556,664
-74% -$268M 0.01% 1227
2023
Q4
$371M Buy
6,194,282
+4,585,286
+285% +$274M 0.02% 809
2023
Q3
$61.2M Buy
1,608,996
+852,331
+113% +$32.4M 0.01% 1393
2023
Q2
$68.9M Buy
756,665
+3,803
+0.5% +$346K 0.01% 1320
2023
Q1
$49.7M Buy
752,862
+452,979
+151% +$29.9M 0.01% 1552
2022
Q4
$15.5M Buy
299,883
+76,607
+34% +$3.96M ﹤0.01% 2595
2022
Q3
$15.3M Sell
223,276
-229,744
-51% -$15.7M ﹤0.01% 2496
2022
Q2
$20.5M Buy
453,020
+199,631
+79% +$9.03M ﹤0.01% 2273
2022
Q1
$12.9M Buy
253,389
+185,730
+275% +$9.44M ﹤0.01% 2600
2021
Q4
$3.2M Sell
67,659
-109,637
-62% -$5.18M ﹤0.01% 4181
2021
Q3
$5.84M Sell
177,296
-52,045
-23% -$1.72M ﹤0.01% 3508
2021
Q2
$14.5M Buy
229,341
+77,317
+51% +$4.89M ﹤0.01% 2546
2021
Q1
$6.52M Buy
152,024
+51,679
+52% +$2.22M ﹤0.01% 3133
2020
Q4
$5.74M Buy
100,345
+60,546
+152% +$3.46M ﹤0.01% 3103
2020
Q3
$1.2M Sell
39,799
-16,591
-29% -$501K ﹤0.01% 4075
2020
Q2
$1.84M Buy
56,390
+6,730
+14% +$220K ﹤0.01% 3670
2020
Q1
$1.33M Sell
49,660
-72,887
-59% -$1.95M ﹤0.01% 3723
2019
Q4
$3.75M Sell
122,547
-289,557
-70% -$8.87M ﹤0.01% 3498
2019
Q3
$9.93M Buy
412,104
+400,191
+3,359% +$9.64M ﹤0.01% 2140
2019
Q2
$303K Sell
11,913
-1,236,481
-99% -$31.4M ﹤0.01% 4843
2019
Q1
$24.3M Buy
1,248,394
+1,191,729
+2,103% +$23.2M 0.01% 1314
2018
Q4
$747K Sell
56,665
-3,647
-6% -$48.1K ﹤0.01% 4504
2018
Q3
$1.07M Sell
60,312
-19,315
-24% -$343K ﹤0.01% 4485
2018
Q2
$1.75M Buy
79,627
+59,125
+288% +$1.3M ﹤0.01% 4201
2018
Q1
$453K Buy
20,502
+1,594
+8% +$35.2K ﹤0.01% 5063
2017
Q4
$410K Buy
+18,908
New +$410K ﹤0.01% 5080